JAK2 and myelodysplastic syndrome: Despite this, the JAK2 V617F mutation may still be valuable in the diagnosis of MPN; for example, a previous study indicated that JAK2 V617F allele evaluation may be used to discriminate MDS from MPN in specimens with bone marrow fibrosis (14).